chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pelvic pain
Clinical narrative: shortness of breath/difficulty breathing; bronchitis cough; chronic bronchitis; pelvic pain; neck hurts to move; sore throat; Difficulty breathing; Really bad headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath/difficulty breathing), COUGH (bronchitis cough), BRONCHITIS CHRONIC (chronic bronchitis), PELVIC PAIN (pelvic pain) and NECK PAIN (neck hurts to move) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ALBUTEROL SULFATE, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT), BUSPIRONE, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), PANTOPRAZOLE, LAMOTRIGINE, LORATADINE (CLARITIN [LORATADINE]) and ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN MIGRAINE) for an unknown indication.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, the patient experienced HEADACHE (Really bad headache). On 09-May-2021, the patient experienced DYSPNOEA (shortness of breath/difficulty breathing), COUGH (bronchitis cough), BRONCHITIS CHRONIC (chronic bronchitis), PELVIC PAIN (pelvic pain), NECK PAIN (neck hurts to move), OROPHARYNGEAL PAIN (sore throat) and DYSPNOEA (Difficulty breathing). At the time of the report, DYSPNOEA (shortness of breath/difficulty breathing), COUGH (bronchitis cough), BRONCHITIS CHRONIC (chronic bronchitis), PELVIC PAIN (pelvic pain), NECK PAIN (neck hurts to move), OROPHARYNGEAL PAIN (sore throat), DYSPNOEA (Difficulty breathing) and HEADACHE (Really bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was reported.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Mobility decreased, Myalgia, Pyrexia
Clinical narrative: low appetite; Limited mobility due to pain; Pain throughout arms, legs, and back; Fever; Chills/Mild chills; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (low appetite), MOBILITY DECREASED (Limited mobility due to pain), CHILLS (Chills/Mild chills), MYALGIA (Pain throughout arms, legs, and back) and PYREXIA (Fever) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.  Concomitant products included OMEPRAZOLE for an unknown indication.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced CHILLS (Chills/Mild chills) and PYREXIA (Fever). On 02-May-2021, the patient experienced MOBILITY DECREASED (Limited mobility due to pain) and MYALGIA (Pain throughout arms, legs, and back). On 08-May-2021, the patient experienced DECREASED APPETITE (low appetite). On 03-May-2021, CHILLS (Chills/Mild chills) and PYREXIA (Fever) had resolved. On 04-May-2021, MOBILITY DECREASED (Limited mobility due to pain) and MYALGIA (Pain throughout arms, legs, and back) had resolved. On 08-May-2021, DECREASED APPETITE (low appetite) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Follow up received and contains NNI
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Rash
Clinical narrative: both feet sore; Rash on his hind quarters; Red feet; face got a little red; redness in neck; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red feet), ERYTHEMA (face got a little red), RASH (redness in neck), PAIN IN EXTREMITY (both feet sore) and RASH (Rash on his hind quarters) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced ERYTHEMA (Red feet), ERYTHEMA (face got a little red), RASH (redness in neck) and RASH (Rash on his hind quarters). On an unknown date, the patient experienced PAIN IN EXTREMITY (both feet sore). On 03-May-2021, ERYTHEMA (Red feet), ERYTHEMA (face got a little red), RASH (redness in neck) and RASH (Rash on his hind quarters) had resolved. At the time of the report, PAIN IN EXTREMITY (both feet sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided. No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow-up received on 01-Apr-2021 included added both feet sore On 09-Jun-2021: Follow-up received on 01-Apr-2021 included no new information. On 08-Jul-2021: Non-significant follow up-IRMS document with no new information
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Type IV hypersensitivity reaction
Clinical narrative: Covid arm; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm) and TYPE IV HYPERSENSITIVITY REACTION (Covid arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (sore arm) and TYPE IV HYPERSENSITIVITY REACTION (Covid arm). At the time of the report, MYALGIA (sore arm) and TYPE IV HYPERSENSITIVITY REACTION (Covid arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Arthralgia, Insomnia, Pyrexia
Clinical narrative: Fever; Lack of sleep; Loss of Taste; Loss of Smell; Joint Pain that feels like being mashed or hit by a train; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of Taste), ANOSMIA (Loss of Smell), ARTHRALGIA (Joint Pain that feels like being mashed or hit by a train), PYREXIA (Fever) and INSOMNIA (Lack of sleep) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced AGEUSIA (Loss of Taste), ANOSMIA (Loss of Smell), ARTHRALGIA (Joint Pain that feels like being mashed or hit by a train) and INSOMNIA (Lack of sleep). On 08-May-2021, the patient experienced PYREXIA (Fever). On 08-May-2021, AGEUSIA (Loss of Taste), ANOSMIA (Loss of Smell) and PYREXIA (Fever) had resolved. At the time of the report, ARTHRALGIA (Joint Pain that feels like being mashed or hit by a train) and INSOMNIA (Lack of sleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment details were provided.
Age: 41.0
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: passed the 42 days window; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (passed the 42 days window) in a 41-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (passed the 42 days window). At the time of the report, PRODUCT DOSE OMISSION ISSUE (passed the 42 days window) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: No new information was added.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vomiting
Clinical narrative: wooziness; vomiting; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (wooziness) and VOMITING (vomiting) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 044B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-May-2021, the patient experienced DIZZINESS (wooziness) and VOMITING (vomiting). At the time of the report, DIZZINESS (wooziness) and VOMITING (vomiting) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Broke out in hives arms/ broke out in hives legs/ broke out in hives a little on her back; Broke out in rash legs, arms and broke out in rash a little on her back; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Broke out in hives arms/ broke out in hives legs/ broke out in hives a little on her back) and RASH (Broke out in rash legs, arms and broke out in rash a little on her back) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038AZ1A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy (Allergy to penicillin).    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced URTICARIA (Broke out in hives arms/ broke out in hives legs/ broke out in hives a little on her back) and RASH (Broke out in rash legs, arms and broke out in rash a little on her back). At the time of the report, URTICARIA (Broke out in hives arms/ broke out in hives legs/ broke out in hives a little on her back) and RASH (Broke out in rash legs, arms and broke out in rash a little on her back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.  Treatment medication include antibiotic 1000mg for 7 days .   This case was linked to US-MODERNATX, INC.-MOD-2021-116493 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Non-Significant Follow-up  on 09-Jul-2021 was  received for initial 1 and it mentioned reporter's Home address On 21-Jul-2021: Non Significant Follow-up Append; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-116493:dose 2
Age: 19.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case reported by a pharmacist, describes the occurrence of administered expired product (patient received vaccine from a punctured vial/the vaccine administered from a punctured vial refrigerated past 12 hours) in a 19-year-old patient, of an unknown gender, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 016C21A) for COVID-19 immunization. No medical history or concomitant medication provided. On May 10, 2021, at 12:25 pm, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On May 10, 2021, patient administered expired product (patient received vaccine from a punctured vial/the vaccine administered from a punctured vial refrigerated past 12 hours). On May 10, 2021, administered expired product (patient received vaccine from the punctured vial/the vaccine administered from a punctured vial refrigerated past 12 hours) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19  vaccine), intramuscular: unknown. The reporter did not provide any causality assessments. Most recent follow-up information incorporated: On Jun 8, 2021: Updated patient demographics, vaccination details and vaccination facility details.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Whole right arm was hurting; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Whole right arm was hurting) and HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 003A21A.) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (Whole right arm was hurting) and HEADACHE (Headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form three times a day. On 06-Feb-2021, PAIN IN EXTREMITY (Whole right arm was hurting) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was not reported. No treatment medication was not reported    This case was linked to US-MODERNATX, INC.-MOD-2021-116503 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: No significant information added.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-116503:dose 2
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Nausea, SARS-CoV-2 antibody test
Clinical narrative: doctorasked me to get tested for Covid; Last night on Sunday, I had dizziness; nausea; Saturday night I had chills again; Next day, felt dizzy; had chills at night; felt dizzy immediately after injection; also had fatigue everyday since I got the shot; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt dizzy immediately after injection), SARS-COV-2 ANTIBODY TEST (doctorasked me to get tested for Covid), DIZZINESS (Next day, felt dizzy), DIZZINESS (Last night on Sunday, I had dizziness) and CHILLS (had chills at night) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced DIZZINESS (felt dizzy immediately after injection), CHILLS (had chills at night) and FATIGUE (also had fatigue everyday since I got the shot). On 07-May-2021, the patient experienced DIZZINESS (Next day, felt dizzy). On 08-May-2021, the patient experienced CHILLS (Saturday night I had chills again). On 09-May-2021, the patient experienced DIZZINESS (Last night on Sunday, I had dizziness) and NAUSEA (nausea). On an unknown date, the patient experienced SARS-COV-2 ANTIBODY TEST (doctorasked me to get tested for Covid). At the time of the report, DIZZINESS (felt dizzy immediately after injection), SARS-COV-2 ANTIBODY TEST (doctorasked me to get tested for Covid), DIZZINESS (Next day, felt dizzy), DIZZINESS (Last night on Sunday, I had dizziness), CHILLS (had chills at night), NAUSEA (nausea), FATIGUE (also had fatigue everyday since I got the shot) and CHILLS (Saturday night I had chills again) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported No treatment medications were reported
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Malaise, Vision blurred
Clinical narrative: blurred vision; Was not feeling well; stayed in bed all day; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Was not feeling well), BEDRIDDEN (stayed in bed all day) and VISION BLURRED (blurred vision) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 08-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-May-2021, the patient experienced MALAISE (Was not feeling well) and BEDRIDDEN (stayed in bed all day). On 10-May-2021, the patient experienced VISION BLURRED (blurred vision). At the time of the report, MALAISE (Was not feeling well) and BEDRIDDEN (stayed in bed all day) outcome was unknown and VISION BLURRED (blurred vision) had not resolved. Not Provided          No treatment medication specified.  Action taken with mRNA-1273 in response to events was not applicable.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Product dose omission issue, SARS-CoV-2 test positive, Vaccination site pain
Clinical narrative: patient was scheduled to get the second dose however they had travelled so they cannot get their second dose; tested positive for covid-19; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (patient was scheduled to get the second dose however they had travelled so they cannot get their second dose), SARS-COV-2 TEST POSITIVE (tested positive for covid-19) and MYALGIA (arm pain) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced MYALGIA (arm pain). On 03-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRODUCT DOSE OMISSION ISSUE (patient was scheduled to get the second dose however they had travelled so they cannot get their second dose) and SARS-COV-2 TEST POSITIVE (tested positive for covid-19). At the time of the report, PRODUCT DOSE OMISSION ISSUE (patient was scheduled to get the second dose however they had travelled so they cannot get their second dose), SARS-COV-2 TEST POSITIVE (tested positive for covid-19) and MYALGIA (arm pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-May-2021, COVID-19: positive (Positive) The Patient tested Positive for COVID-19 on 03-May-2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter. Patient have event like mild symptoms of COVID-19.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Peripheral swelling, Rash, Rash pruritic
Clinical narrative: Rashes are itchy; A rash on her legs (from the knee down), a rash on the lower part of her arm, wrist, and on the back of both hands; Feet swelled up; Feet are red; when she itches the rash it hurts; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Rashes are itchy), RASH (A rash on her legs (from the knee down), a rash on the lower part of her arm, wrist, and on the back of both hands), PERIPHERAL SWELLING (Feet swelled up), ERYTHEMA (Feet are red) and PAIN (when she itches the rash it hurts) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Atrial fibrillation, Thyroid disorder NOS, ADHD and Depression. Concomitant products included VITAMIN B NOS for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (Rashes are itchy), RASH (A rash on her legs (from the knee down), a rash on the lower part of her arm, wrist, and on the back of both hands), PERIPHERAL SWELLING (Feet swelled up), ERYTHEMA (Feet are red) and PAIN (when she itches the rash it hurts). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (Rashes are itchy), RASH (A rash on her legs (from the knee down), a rash on the lower part of her arm, wrist, and on the back of both hands), PERIPHERAL SWELLING (Feet swelled up), ERYTHEMA (Feet are red) and PAIN (when she itches the rash it hurts) outcome was unknown.            Concomitant product information includes Atrial Fibrillation medication,Blood Pressure Medication,Thyroid Medication,Reflux medications,Prodiotic,Antidepressants,ADHD medications,Vitamins Treatment information includes Ice pack on hand and got a cortisone injection in her lower back since it was hurting really bad. Patient stated that discontinued taking glucosamine and another oil. Action taken with mRNA-1273 in response to the events is not applicable   This case was linked to MOD-2021-116468 (Patient Link).
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site streaking
Clinical narrative: Red streak on injection arm 2 inches long/started seeing red streak forming about 2 hrs after injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE STREAKING (Red streak on injection arm 2 inches long/started seeing red streak forming about 2 hrs after injection) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040azia and 032a21a) for COVID-19 vaccination.     Concomitant products included BISOPROLOL and BENAZEPRIL for Blood pressure management, METFORMIN for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE STREAKING (Red streak on injection arm 2 inches long/started seeing red streak forming about 2 hrs after injection). At the time of the report, VACCINATION SITE STREAKING (Red streak on injection arm 2 inches long/started seeing red streak forming about 2 hrs after injection) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow up received on 10-MAY-2021, Patient information updated. On 22-Jun-2021: Follow up received on 22-JUN-2021: Vaccine lot/batch details updated, Concomitant medications updated, Event outcome updated.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm (from first dose); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm (from first dose)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L2074) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm (from first dose)). At the time of the report, PAIN IN EXTREMITY (sore arm (from first dose)) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-116496.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Dose 1 details were added.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Head discomfort, Headache
Clinical narrative: Fatigue; Dizziness; Discomfort in my head; Headaches; Grogginess; Mood swings; Nausea; Weakness; It got to the point where I couldn't go into work It affected me doing day to day things; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), DIZZINESS (Dizziness), HEAD DISCOMFORT (Discomfort in my head), HEADACHE (Headaches) and SOMNOLENCE (Grogginess) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue), DIZZINESS (Dizziness), HEAD DISCOMFORT (Discomfort in my head), HEADACHE (Headaches), SOMNOLENCE (Grogginess), MOOD SWINGS (Mood swings), NAUSEA (Nausea), ASTHENIA (Weakness) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (It got to the point where I couldn't go into work It affected me doing day to day things). At the time of the report, FATIGUE (Fatigue), DIZZINESS (Dizziness), HEAD DISCOMFORT (Discomfort in my head), HEADACHE (Headaches), SOMNOLENCE (Grogginess), MOOD SWINGS (Mood swings), NAUSEA (Nausea), ASTHENIA (Weakness) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (It got to the point where I couldn't go into work It affected me doing day to day things) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Mood swings, Nausea, Somnolence
Clinical narrative: Fatigue; Dizziness; Discomfort in my head; Headaches; Grogginess; Mood swings; Nausea; Weakness; It got to the point where I couldn't go into work It affected me doing day to day things; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), DIZZINESS (Dizziness), HEAD DISCOMFORT (Discomfort in my head), HEADACHE (Headaches) and SOMNOLENCE (Grogginess) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue), DIZZINESS (Dizziness), HEAD DISCOMFORT (Discomfort in my head), HEADACHE (Headaches), SOMNOLENCE (Grogginess), MOOD SWINGS (Mood swings), NAUSEA (Nausea), ASTHENIA (Weakness) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (It got to the point where I couldn't go into work It affected me doing day to day things). At the time of the report, FATIGUE (Fatigue), DIZZINESS (Dizziness), HEAD DISCOMFORT (Discomfort in my head), HEADACHE (Headaches), SOMNOLENCE (Grogginess), MOOD SWINGS (Mood swings), NAUSEA (Nausea), ASTHENIA (Weakness) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (It got to the point where I couldn't go into work It affected me doing day to day things) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Discharge, Dry skin, Lip exfoliation, Lip haemorrhage
Clinical narrative: lips swelled up; lips bled; ips peeled off; Clear liquid came out of the rash; On arm noticed little bumps like a mole but not a mole; rash, it itched; skin was soft now its rough; arm was sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LIP SWELLING (lips swelled up), LIP HAEMORRHAGE (lips bled), LIP EXFOLIATION (ips peeled off), DISCHARGE (Clear liquid came out of the rash) and BLISTER (On arm noticed little bumps like a mole but not a mole) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced LIP SWELLING (lips swelled up), LIP HAEMORRHAGE (lips bled), LIP EXFOLIATION (ips peeled off), DISCHARGE (Clear liquid came out of the rash), BLISTER (On arm noticed little bumps like a mole but not a mole), RASH PRURITIC (rash, it itched), DRY SKIN (skin was soft now its rough) and PAIN IN EXTREMITY (arm was sore). At the time of the report, LIP SWELLING (lips swelled up), LIP HAEMORRHAGE (lips bled), LIP EXFOLIATION (ips peeled off), DISCHARGE (Clear liquid came out of the rash), BLISTER (On arm noticed little bumps like a mole but not a mole), RASH PRURITIC (rash, it itched), DRY SKIN (skin was soft now its rough) and PAIN IN EXTREMITY (arm was sore) outcome was unknown.            No concomitant medications were reported. Treatment medications includes: Antibiotic 1000mg for 7 days, not otherwise specified.    This case was linked to US-MODERNATX, INC.-MOD-2021-116481 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Patient  received the follow up form and patient is having troubles emailing this form back. Patient  doesn't have access to a fax machine. Patient  asked for a mailing address that  can use to mail the form back; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-116481:dose 1
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Pain in extremity, Rash pruritic
Clinical narrative: lips swelled up; lips bled; ips peeled off; Clear liquid came out of the rash; On arm noticed little bumps like a mole but not a mole; rash, it itched; skin was soft now its rough; arm was sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LIP SWELLING (lips swelled up), LIP HAEMORRHAGE (lips bled), LIP EXFOLIATION (ips peeled off), DISCHARGE (Clear liquid came out of the rash) and BLISTER (On arm noticed little bumps like a mole but not a mole) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced LIP SWELLING (lips swelled up), LIP HAEMORRHAGE (lips bled), LIP EXFOLIATION (ips peeled off), DISCHARGE (Clear liquid came out of the rash), BLISTER (On arm noticed little bumps like a mole but not a mole), RASH PRURITIC (rash, it itched), DRY SKIN (skin was soft now its rough) and PAIN IN EXTREMITY (arm was sore). At the time of the report, LIP SWELLING (lips swelled up), LIP HAEMORRHAGE (lips bled), LIP EXFOLIATION (ips peeled off), DISCHARGE (Clear liquid came out of the rash), BLISTER (On arm noticed little bumps like a mole but not a mole), RASH PRURITIC (rash, it itched), DRY SKIN (skin was soft now its rough) and PAIN IN EXTREMITY (arm was sore) outcome was unknown.            No concomitant medications were reported. Treatment medications includes: Antibiotic 1000mg for 7 days, not otherwise specified.    This case was linked to US-MODERNATX, INC.-MOD-2021-116481 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Patient  received the follow up form and patient is having troubles emailing this form back. Patient  doesn't have access to a fax machine. Patient  asked for a mailing address that  can use to mail the form back; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-116481:dose 1
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Fatigue, Sinusitis
Clinical narrative: Tiredness after second vaccine dose; Loss of taste after second vaccine dose; Loss of smell after second vaccine dose; Sinus infection after second vaccine dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of AGEUSIA (Loss of taste after second vaccine dose), ANOSMIA (Loss of smell after second vaccine dose), SINUSITIS (Sinus infection after second vaccine dose) and FATIGUE (Tiredness after second vaccine dose) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 030M20A) for COVID-19 vaccination.     The patient's past medical history included Sinus infection in March 2021 and Breast cancer.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced FATIGUE (Tiredness after second vaccine dose). In March 2021, the patient experienced AGEUSIA (Loss of taste after second vaccine dose), ANOSMIA (Loss of smell after second vaccine dose) and SINUSITIS (Sinus infection after second vaccine dose). On 12-Mar-2021, FATIGUE (Tiredness after second vaccine dose) had resolved. At the time of the report, AGEUSIA (Loss of taste after second vaccine dose) and ANOSMIA (Loss of smell after second vaccine dose) had not resolved and SINUSITIS (Sinus infection after second vaccine dose) outcome was unknown.            No concomitant medications were mentioned. No treatment drugs were reported. She went to the Doctor, and was told that her symptoms are side effects of the vaccine. Patient has a history of breast cancer and do not use her left arm for vaccination or blood draws.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest X-ray, Condition aggravated, Dyspnoea, Myalgia
Clinical narrative: immune system was effected and had a flair up of my autoimmune disease; muscle ache mostly on right side of shoulder, muscle ache mostly on right side under breast; horrible shortness of breath; energy level down; Pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (horrible shortness of breath), ASTHENIA (energy level down), PAIN (Pain), CONDITION AGGRAVATED (immune system was effected and had a flair up of my autoimmune disease) and MYALGIA (muscle ache mostly on right side of shoulder, muscle ache mostly on right side under breast) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     Concurrent medical conditions included Lichen sclerosus since 2021 and Collagen-vascular disease since 2021. Concomitant products included VITAMIN B12 NOS, DHEA, 3,3'-DIINDOLYLMETHANE, INDOLE-3-CARBINOL, TOCOPHERYL ACETATE (ESTRODIM), ASTAXANTHIN, LIPASE, DOCOSAHEXAENOIC ACID, EICOSAPENTAENOIC ACID (EPA DHA 720), PREGNENOLONE, IRON, ACETYL-L-CARNITINE, PANTOTHENIC ACID, IODINE (KELP [IODINE]), GAMMA-LINOLENIC ACID, UBIQUINOL, ZINC, MENAQUINONE-7 (VITAMIN K 2), THYROID (ARMOUR THYROID) and VITAMIN D3 for an unknown indication.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced DYSPNOEA (horrible shortness of breath), ASTHENIA (energy level down), PAIN (Pain) and MYALGIA (muscle ache mostly on right side of shoulder, muscle ache mostly on right side under breast). On an unknown date, the patient experienced CONDITION AGGRAVATED (immune system was effected and had a flair up of my autoimmune disease). At the time of the report, DYSPNOEA (horrible shortness of breath), ASTHENIA (energy level down), PAIN (Pain), CONDITION AGGRAVATED (immune system was effected and had a flair up of my autoimmune disease) and MYALGIA (muscle ache mostly on right side of shoulder, muscle ache mostly on right side under breast) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-May-2021, Chest X-ray: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also included "Rhodian". Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jul-2021: Follow up received. The new event condition aggravated was added.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: immune system was effected and had a flair up of my autoimmune disease; muscle ache mostly on right side of shoulder, muscle ache mostly on right side under breast; horrible shortness of breath; energy level down; Pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (horrible shortness of breath), ASTHENIA (energy level down), PAIN (Pain), CONDITION AGGRAVATED (immune system was effected and had a flair up of my autoimmune disease) and MYALGIA (muscle ache mostly on right side of shoulder, muscle ache mostly on right side under breast) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     Concurrent medical conditions included Lichen sclerosus since 2021 and Collagen-vascular disease since 2021. Concomitant products included VITAMIN B12 NOS, DHEA, 3,3'-DIINDOLYLMETHANE, INDOLE-3-CARBINOL, TOCOPHERYL ACETATE (ESTRODIM), ASTAXANTHIN, LIPASE, DOCOSAHEXAENOIC ACID, EICOSAPENTAENOIC ACID (EPA DHA 720), PREGNENOLONE, IRON, ACETYL-L-CARNITINE, PANTOTHENIC ACID, IODINE (KELP [IODINE]), GAMMA-LINOLENIC ACID, UBIQUINOL, ZINC, MENAQUINONE-7 (VITAMIN K 2), THYROID (ARMOUR THYROID) and VITAMIN D3 for an unknown indication.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced DYSPNOEA (horrible shortness of breath), ASTHENIA (energy level down), PAIN (Pain) and MYALGIA (muscle ache mostly on right side of shoulder, muscle ache mostly on right side under breast). On an unknown date, the patient experienced CONDITION AGGRAVATED (immune system was effected and had a flair up of my autoimmune disease). At the time of the report, DYSPNOEA (horrible shortness of breath), ASTHENIA (energy level down), PAIN (Pain), CONDITION AGGRAVATED (immune system was effected and had a flair up of my autoimmune disease) and MYALGIA (muscle ache mostly on right side of shoulder, muscle ache mostly on right side under breast) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-May-2021, Chest X-ray: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also included "Rhodian". Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jul-2021: Follow up received. The new event condition aggravated was added.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Tinnitus
Clinical narrative: ringing in his ears; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TINNITUS (ringing in his ears) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M2077 and 027L2074) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TINNITUS (ringing in his ears) and HEADACHE (headache). At the time of the report, TINNITUS (ringing in his ears) and HEADACHE (headache) had not resolved.            This case was linked to MOD-2021-116491, MOD-2021-116491 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Non significant follow up received on 07 JUN 2021, vaccination information were updated
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     Concomitant products included MULTIVITAMIN FOR WOMEN for an unknown indication.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products used included Women's multivitamin and birth control pills.  No treatment medication was provided.  The patient was rescheduled to receive the 2nd dose on 14May2021. However, her partner will undergo an operation that day so she had to reschedule.The medical center rescheduled her on 08May2021 which was only 22 days after the initial dose.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Illness, Malaise, Musculoskeletal pain
Clinical narrative: sore on his lower back kidney area; tendon pain; shooting pain in his left arm; Muscle and tendon pain in different areas of body; Musculoskeletal pain; very ill; felt awful; Joint Pain; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very ill), MALAISE (felt awful), BACK PAIN (sore on his lower back kidney area), TENDON PAIN (tendon pain) and MUSCULOSKELETAL PAIN (Musculoskeletal pain) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced ILLNESS (very ill), MALAISE (felt awful) and ARTHRALGIA (Joint Pain). On 09-May-2021, the patient experienced MUSCULOSKELETAL PAIN (Musculoskeletal pain). On an unknown date, the patient experienced BACK PAIN (sore on his lower back kidney area), TENDON PAIN (tendon pain), PAIN IN EXTREMITY (shooting pain in his left arm) and MYALGIA (Muscle and tendon pain in different areas of body). On 07-Apr-2021, ILLNESS (very ill), MALAISE (felt awful) and ARTHRALGIA (Joint Pain) had resolved. At the time of the report, BACK PAIN (sore on his lower back kidney area), TENDON PAIN (tendon pain), MUSCULOSKELETAL PAIN (Musculoskeletal pain), PAIN IN EXTREMITY (shooting pain in his left arm) and MYALGIA (Muscle and tendon pain in different areas of body) outcome was unknown. Not Provided          No concomitant medications were reported. Treatment medication includes: 2 Tylenols Patient reported to experienced a right ankle shooting pain up to his left knee, it was unbearable and occurred at different times.  Patient went to the Chiropractor but everything was normal. On 09-MAY-2021, Patient reported there was a shooting pain in his arm, and mid finger was tender and a sharp pain in his arm as he was unable to move his arm.  Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity, Tendon pain
Clinical narrative: sore on his lower back kidney area; tendon pain; shooting pain in his left arm; Muscle and tendon pain in different areas of body; Musculoskeletal pain; very ill; felt awful; Joint Pain; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very ill), MALAISE (felt awful), BACK PAIN (sore on his lower back kidney area), TENDON PAIN (tendon pain) and MUSCULOSKELETAL PAIN (Musculoskeletal pain) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced ILLNESS (very ill), MALAISE (felt awful) and ARTHRALGIA (Joint Pain). On 09-May-2021, the patient experienced MUSCULOSKELETAL PAIN (Musculoskeletal pain). On an unknown date, the patient experienced BACK PAIN (sore on his lower back kidney area), TENDON PAIN (tendon pain), PAIN IN EXTREMITY (shooting pain in his left arm) and MYALGIA (Muscle and tendon pain in different areas of body). On 07-Apr-2021, ILLNESS (very ill), MALAISE (felt awful) and ARTHRALGIA (Joint Pain) had resolved. At the time of the report, BACK PAIN (sore on his lower back kidney area), TENDON PAIN (tendon pain), MUSCULOSKELETAL PAIN (Musculoskeletal pain), PAIN IN EXTREMITY (shooting pain in his left arm) and MYALGIA (Muscle and tendon pain in different areas of body) outcome was unknown. Not Provided          No concomitant medications were reported. Treatment medication includes: 2 Tylenols Patient reported to experienced a right ankle shooting pain up to his left knee, it was unbearable and occurred at different times.  Patient went to the Chiropractor but everything was normal. On 09-MAY-2021, Patient reported there was a shooting pain in his arm, and mid finger was tender and a sharp pain in his arm as he was unable to move his arm.  Action taken with mRNA-1273 in response to the events was not Applicable.